Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults

Clinical trial NCT01267058 · COMPLETED

Trial details

NCT number: NCT01267058
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Pertussis Tetanus

Start date: 1997-09-01
Primary completion: 1998-02-01
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.